Louis Chen
Stock Analyst at Scotiabank
(0.29)
# 4,376
Out of 5,134 analysts
11
Total ratings
27.27%
Success rate
-42.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Sector Outperform | $140 → $177 | $155.27 | +13.99% | 2 | Feb 11, 2026 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $4.85 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $53.33 | +3.13% | 1 | Feb 24, 2022 |
Gilead Sciences
Feb 11, 2026
Maintains: Sector Outperform
Price Target: $140 → $177
Current: $155.27
Upside: +13.99%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.85
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $53.33
Upside: +3.13%